glp-1-based therapies Optimizing GLP-1 for obesity and diabetes management GLP-1 Drugs & What They

As with all litigation, the presence of an MDL or a pending class claim can evolve over time, and anyone considering a claim should consult experienced counsel to understand available legal avenues

At the same time, several developments in February point toward a future where FDA-approved GLP-1s become more financially accessible

For cohort and casecontrol designs, study quality was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS)

A small human study examining the addition of phentermine to liraglutide found no meaningful additional weight loss compared to liraglutide alone

The most successful strategy for maintaining GLP-1 results involves building the behavioral foundation during treatment

Meanwhile, antibiotic-treated cohorts showed diminished renal and intestinal effects of empagliflozin, supporting a microbiota-dependent mechanism [37]